trial

Effects of Auditory Stimulation on Sleep and Memory in Schizophrenia

NCTId NCT04783571
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Active Not Recruiting
Enrollment 70 (estimated)
Sponsored by Massachusetts General Hospital
Primary completion 2027-12-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Active Not Recruiting
Enrollment
70 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Double
Start
2020-04-13
Primary completion
2027-12-31
Eligibility
ALL · 18 Years · 50 Years

Interventions & indications

Drugs
Auditory Stimulation

Sponsors

Massachusetts General HospitalLead Sponsor

Investigators

1
Dara S. Manoach, PhDPrincipal Investigator

Sites

1 total
Boston, United States

Facts & assertions

4 sourced
Enrollment
70
Phase
NA
Primary Completion Date
2027-12-31
Status
ACTIVE_NOT_RECRUITING
relationships
The graph out of here
drug
Auditory Stimulation
drug
lead_sponsor
Massachusetts General Hospital
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Dara S. Manoach, PhD
person